✦ LIBER ✦

Current treatments in nonalcoholic steatohepatitis

✍ Scribed by Dawn M. Torres; Stephen A. Harrison

Publisher: Springer
Year: 2007
Tongue: English
Weight: 139 KB
Volume: 10
Category: Article
ISSN: 1092-8472
DOI: 10.1007/s11938-007-0042-y

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Current and novel therapies for the trea

Current and novel therapies for the treatment of nonalcoholic steatohepatitis

✍ David van der Poorten; Jacob George 📂 Article 📅 2007 🏛 Springer-Verlag 🌐 English ⚖ 249 KB

Pioglitazone and Nonalcoholic Steatohepa

Pioglitazone and Nonalcoholic Steatohepatitis

✍ Guenther Boden 📂 Article 📅 2007 🏛 Current Science Inc. 🌐 English ⚖ 90 KB

Nonalcoholic steatohepatitis in children

✍ Eve A. Roberts 📂 Article 📅 2003 🏛 Springer 🌐 English ⚖ 914 KB

Insulin sensitizers in nonalcoholic stea

Insulin sensitizers in nonalcoholic steatohepatitis

✍ Stephen A. Harrison; Steven Schenker; Kenneth Cusi 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 378 KB 👁 1 views

We read with great interest the article by Stepanova et al. 1 In this report from the United States with 10,582 eligible individuals (1.52% of whom were positive for hepatitis C virus [HCV] antibody [anti-HCV]), the rate of insurance coverage was significantly lower in patients with HCV infection (6

Insulin sensitizers in nonalcoholic fatt

Insulin sensitizers in nonalcoholic fatty liver disease and steatohepatitis: Current status

✍ Lance L. Stein; Mamie H. Dong; Rohit Loomba 📂 Article 📅 2009 🏛 Springer Healthcare Communications 🌐 English ⚖ 238 KB

A pilot study of pioglitazone treatment

A pilot study of pioglitazone treatment for nonalcoholic steatohepatitis

✍ Kittichai Promrat; Glen Lutchman; Gabriel I. Uwaifo; Renee J. Freedman; Alejandr 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 146 KB 👁 2 views

Nonalcoholic steatohepatitis (NASH) is a common chronic liver disease for which there is no known effective therapy. A proportion of patients with NASH progress to advanced fibrosis and cirrhosis. NASH is considered one of the clinical features of the metabolic syndrome in which insulin resistance p